Ex-Stryker CEO to head disinfectant firm

Eight months after his abrupt resignation from Stryker ($SYK), Stephen MacMillan has landed a job as the CEO of sBioMed, an Orem, UT, maker of clinical anti-infection agents. In an interview with Mass Device, MacMillan described his very public exit from Stryker as "unfair, unfortunate and personally challenging," but said he's enthusiastic to start at sBioMed, which is scaling up commercialization of its Steriplex SD solution. Release | Interview

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.